Bristol-Myers Squibb Company News - August 2026
Dodge & Cox Nearly Exits Bristol-Myers Squibb (BMY) Stake
In a significant portfolio shift, investment manager Dodge & Cox virtually eliminated its position in Bristol-Myers Squibb during the second quarter of 2026....
🟢 Bristol-Myers Squibb is trading 7.6% up today after strong Q2 earnings and a guidance hike
Bristol-Myers Squibb is trading at $70.24 (7.6% up) today following a strong Q2 2026 earnings report and a substantial full-year guidance raise. • Management...
AstraZeneca Weighs Bristol Myers Merger, Targeting $400 Billion Market Value
UK-based AstraZeneca Plc held preliminary merger talks with U.S. rival Bristol Myers Squibb Co. The Financial Times reported the discussions citing people...